Blocking glutamine pumps suppresses melanoma cell growth

February 19, 2014
Jeff Holst in his lab at the Centenary Institute

The latest research from Sydney's Centenary Institute and the University of Sydney suggests we could.

Last year the researchers showed they could starve . Now a further discovery opens up the prospect of a new class of drugs that could work across a range of cancers including .

Australia has the highest rate of melanoma in the world. It is the deadliest form of , and third most common in Australia.

Unlike normal cells, melanoma and other cancer cells rely on the amino acid glutamine instead of glucose for the energy required to divide and grow. Thus, in order to fuel their rapid growth, cancer cells need to pump glutamine into their cells.

New research published today in the International Journal of Cancer has found that not only do have more glutamine pumps on their surface, but that blocking these pumps stops their growth. The work was led by Dr Jeff Holst, who heads the Centenary Institute's Origins of Cancer Research Group, together with post-doctoral fellow Dr Qian (Kevin) Wang.

"We've shown that if we starve melanoma of these essential nutrients, we can stop the cancer from growing," says Dr Holst. "This involves blocking the protein pumps that move glutamine into tumour cells, which successfully slowed the growth of the tumours in cell cultures", he says.

Although often curable if detected early, melanoma is one of the most difficult cancers to treat once it has spread, says Dr Holst, because it rapidly develops resistance to known therapies. "But a drug that specifically targets and inhibits the glutamine pump will give us a new and different approach from current treatments."

"This work is leading a new wave with potential to develop cancer therapeutic agents. These drug targets, rather than mutations specific to the cancer, are exaggerated normal processes," says Centenary Executive Director Mathew Vadas.

"This is a long journey to the clinic, but it's an exciting development," Dr Holst says. He hopes such a compound can be developed and tested in five to 10 years.

Last year Dr Holst's group published a paper in the Journal of the National Cancer Institute showing that prostate require another amino acid, leucine, for their growth. "We first demonstrated this nutrient pumping mechanism in prostate cancers, and it now looks like it occurs in a broad range of cancers, particularly solid cancers such as melanoma. This opens the possibility of designing therapies that can be used to block nutrient pumps across multiple cancers."

Explore further: Starving prostate cancer

More information: Wang, Q., Beaumont, K. A., Otte, N. J., Font, J., Bailey, C. G., van Geldermalsen, M., Sharp, D. M., Tiffen, J. C., Ryan, R. M., Jormakka, M., Haass, N. K., Rasko, J. E.J. and Holst, J. (2014), "Targeting glutamine transport to suppress melanoma cell growth." Int. J. Cancer. DOI: 10.1002/ijc.28749

Related Stories

Starving prostate cancer

November 2, 2011
(Medical Xpress) -- Researchers at the Centenary Institute in Sydney have discovered a potential future treatment for prostate cancer—through starving the tumor cells of an essential nutrient they need to grow rapidly.

A tiny RNA with a big role in melanoma

February 18, 2014
A Yale-led study has identified a key mechanism in the regulation of gene expression that promotes the proliferation of melanoma cells. The finding opens a possible avenue for development of treatments that target this mechanism. ...

Study reveals how cancer cells thrive in oxygen-starved tumors

February 4, 2014
A new study identifies the molecular pathway that enables cancer cells to grow in areas of a tumor where oxygen levels are low, a condition called hypoxia.

Proteins that deliver leucine to prostate cancer cells are therapeutic targets

September 19, 2013
Like normal cells, cancer cells require amino acids for growth, maintenance, and cell signaling, and L-type amino acid transporters (LATs) are the delivery vehicles that supply them. Metastatic, castration-resistant prostate ...

New prostate cancer drugs may not be targeting root cause of disease, scientists warn

January 27, 2014
(Medical Xpress)—New drugs being developed for the treatment of prostate cancer may not be targeting the root cause of the disease, according to research published today (Friday, 24 January 2014) in Cell Death & Differentiation.

Recommended for you

Major study of genetics of breast cancer provides clues to mechanisms behind the disease

October 23, 2017
Seventy-two new genetic variants that contribute to the risk of developing breast cancer have been identified by a major international collaboration involving hundreds of researchers worldwide.

Microbiologists contribute to possible new anti-TB treatment path

October 23, 2017
As part of the long effort to improve treatment of tuberculosis (TB), microbiologists led by Yasu Morita at the University of Massachusetts Amherst report that they have for the first time characterized a protein involved ...

New study shows how cells can be led down non-cancer path

October 23, 2017
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells. In a ...

Proton therapy lowers treatment side effects in pediatric head and neck cancer patients

October 23, 2017
Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional photon radiation, and it will result in similar outcomes with less impact on quality of life. Researchers from ...

Big Data shows how cancer interacts with its surroundings

October 23, 2017
By combining data from sources that at first seemed to be incompatible, UC San Francisco researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they ...

Symptom burden may increase hospital length of stay, readmission risk in advanced cancer

October 23, 2017
Hospitalized patients with advanced cancer who report more intense and numerous physical and psychological symptoms appear to be at risk for longer hospital stays and unplanned hospital readmissions. The report from a Massachusetts ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.